Delineating selective vulnerability of inhibitory interneurons in Alpers' syndrome. (2022)
Attributed to:
MRC Strategic Award to establish an International Centre for Genomic Medicine in Neuromuscular Diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/nan.12833
PubMed Identifier: 35790454
Publication URI: http://europepmc.org/abstract/MED/35790454
Type: Journal Article/Review
Volume: 48
Parent Publication: Neuropathology and applied neurobiology
Issue: 6
ISSN: 0305-1846